Clinical presentation of subacute sclerosing panencephalitis in Papua New Guinea

Tropical Medicine and International Health

Volumn 8, Issue 3, 2003, Pages 219-227

  Mgone, Charles S ^a,f   Mgone, Joyce M ^b,e   Takasu, Toshiaki ^c   Miki, Kenji ^c   Kawanishi, Ryuta ^c   Asuo, Peter G ^b,e   Kono, Jacinta ^a   Komase, Katsuhiro ^d   Alpers, Michael P ^a  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b Goroka Base General Hospital   (Papua New Guinea)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KITASATO INSTITUTE   (Japan)

^e Goroka Base Hospital   (Papua New Guinea)

^f African Malaria Network Trust   (Tanzania)

Author keywords

Clinical features of subacute sclerosing panencephalitis; Eastern highlands; Papua New Guinea

Indexed keywords

CHILD; CHILD HEALTH; ENCEPHALITIS; MEASLES;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; ELECTROENCEPHALOGRAPHY; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PAPUA NEW GUINEA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS GENOME;

ADOLESCENT; AGE DISTRIBUTION; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; SEX DISTRIBUTION; SUBACUTE SCLEROSING PANENCEPHALITIS;

PAPUA NEW GUINEA;

MEASLES VIRUS; SUBACUTE SCLEROSING PANENCEPHALITIS VIRUS;

EID: 0242668866     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.2003.01020.x     Document Type: Article

References (44)

1. Alpers M & Gajdusek DC (1965) Changing patterns of kuru: epidemiological changes in the period of increasing contact of the Fore people with western civilization. American Journal of Tropical Medicine and Hygiene 14, 852-879.
2. Anlar B, Kose G, Gurer Y, Altunbasak S, Haspolat S & Okan M (2001) Changing epidemiological features of subacute sclerosing panencephalitis. Infection 29, 192-195.
3. Anonymous (1990) SSPE in the developing world. Lancet 336, 600.
4. Baguley DM & Glasgow GL (1973) Subacute sclerosing panencephalitis and Salk vaccine. Lancet 1, 763-765.
5. Bakir TMF, Hossain A, Ramia S & Sinha NP (1988) Seroepidemiology of mumps, measles, and subacute panencephalitis in Saudi Arabia. Journal of Tropical Pediatrics 34, 254-256.
6. Bass AG (1993) Vaccines in the national immunization programme. Papua New Guinea Medical Journal 36, 141-157.
7. Basu S, Patawari AK, Aneja S, Anand VK, Seth A & Taluja V (2000) Subacute sclerosing panencephalitis: a clinical dilemma. Journal of Tropical Pediatrics 46, 380-381.
8. Bloch AB, Orenstein WA, Stetler HC et al. (1985) Health impact of measles vaccination in the United States. Pediatrics 76, 524-532.
9. Bonthius DJ, Stanek N & Grose C (2000) Subacute sclerosing panencephalitis, a measles complication, in an internationally adopted child. Emerging Infectious Diseases 6, 377-381.
10. Carman WF & Johnson S (1989) Subacute sclerosing panencephalitis in South Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 117-118.
11. Coakley KJ, Coakley CA, Spooner V, Smith TA, Javati A & Kajoi M (1991) A review of measles admissions and deaths in paediatric ward of Goroka Base Hospital during 1989. Papua New Guinea Medical Journal 34, 6-12.
12. Detels R, Brody JA, McNew J & Edgar AH (1973) Further epidemiologic studies of subacute sclerosing panencephalitis. Lancet 2, 11-14.
13. Doǧulu CF, Ciǧer A, Saygi S, Renda Y & Yalaz K (1995) Atypical EEG findings in subacute sclerosing panencephalitis. Clinical Electroencephalography 26, 193-199.
14. Dyken PR (1985) Subacute sclerosing panencephalitis. Neurosurgery Clinics of North America 3, 173-196.
15. Dyken PR (2001) Neuroprogressive disease of post-infectious origin: A review of a resurging subacute sclerosing panencephalitis (SSPE). Mental Retardation Development Disability Research Review 7, 217-225.
16. Jabbour JT, Garcia JH, Lemmi H, Ragland J, Duenas DA & Sever JL (1969) Subacute sclerosing panencephalitis: a multi-disciplinary study of eight cases. Journal of the American Medical Association 207, 2248-2254.
17. Jabbour JT, Duenas A, Sever JL, Krebs HM & Horta-Barbosa LJ (1972) Epidemiology of subacute sclerosing panencephalitis. Journal of the American Medical Association 220, 959-962.
18. Kondo K, Takasu T & Akhtar A (1988) Neurological diseases in Karachi, Pakistan - elevated occurrence of subacute sclerosing panencephalitis. Neuroepidemiology 7, 66-80.
19. Lucas KM, Sanders RC, Rongap A, Rongap T, Pinai S & Alpers MP (1992) Subacute sclerosing panencephalitis (SSPE) in Papua New Guinea: a high incidence in young children. Epidemiology and Infection 108, 547-553.
20. Lucas K (1993) Subacute sclerosing panencephalitis in Papua New Guinea. Papua New Guinea Medical Journal 36, 185-186.
21. Mackenzie DJM, Kipps A & McDonald R (1975) Subacute sclerosing panencephalitis in southern Africa. South African Medical Journal 49, 2083-2086.
22. Mgone JM, Mgone CS, Duke T, Frank D & Yeka W (2000) Control measures and the outcome of the measles epidemic of 1999 in the Eastern Highlands Province. Papua New Guinea Medical Journal 43, 91-97.
23. Miki K, Komase K, Mgone CS et al. (2002) Molecular analysis of measles virus genome derived from SSPE and acute measles patients in Papua New Guinea. Journal of Medical Virology 68, 105-112.
24. Miller CL (1983) Current impact of measles in the United Kingdom. Reviews of Infectious Diseases 5, 439-444.
25. Miller C, Farrington CP & Harbert K (1992) The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989. International Journal of Epidemiology 21, 998-1006.
26. Modie JW, MacKenzie DJM & Kipps A (1980) Subacute sclerosing panencephalitis in Southern Africa. South African Medical Journal 58, 964-967.
27. Modlin JF, Jabbour JT, Witte JJ & Halsey NA (1977) Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis. Pediatrics 59, 505-512.
28. Modlin JF, Halsey NA, Eddins DL et al. (1979) Epidemiology of sclerosing panencephalitis. Pediatrics 94, 231-236.
29. Nakayama T, Mori T, Yamaguchi S et al. (1995) Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Research 35, 1-16.
30. Papua New Guinea Department of Public Health (1974) Papua New Guinea Health Plan 1974-1978. Department of Public Health, Port Moresby, p. 244.
31. Papua New Guinea Department of Health Promotive and Preventive Health Services (1998) The routine immunization results for 1990-1998 and some immunizable disease reports from the Health Information System. Department of Health, Port Moresby.
32. Radhakrishnan K, Thacker AK, Maloo JC, Gerryo SE & Moussa ME (1988) Descriptive epidemiology of some rare neurological diseases in Benghazi, Libya. Neuroepidemiology 7, 159-164.
33. Sanders RC, Brian M, Rongap A, Watt PD & Alpers MP (1990) High incidence of subacute sclerosing panencephalitis (SSPE) in young children in Papua New Guinea. Medical Journal of Australia 153, 740.
34. Schneider-Schaulies J, Niewiesk S, Schineider-Schaulies S & ter Meulen V (1999) Measles in the CNS: the role of viral and host factors for the establishment and the maintenance of a persistent infection. Journal of Neuorovirology 5, 613-622.
35. Schneider-Schaulies S & ter Meulen V (1999) Pathogenic aspects of measles virus infections. Archives of Virology Supplementum 15, 139-158.
36. Schoub BD, Johnson S & McAnermey JM (1990) Subacute sclerosing panencephalitis in the developing world. Lancet 336, 1314.
37. Sharp GB, Laney SM, Westmoreland BF & Groover RV (1991) Atypical electroencephalographic pattern in a patient with subacute sclerosing panencephalitis. Electroencephalography and Clinical Neurophysiology 78, 311-313.
38. Soffer D, Rannon L, Alter M, Kahana E & Feldman S (1976) Subacute sclerosing panencephalitis: an epidemiologic study in Israel. American Journal of Epidemiology 103, 610-614.
39. Takasu T, Kondo K & Akhtar A (1992) Elevated ratio of late measles among subacute sclerosing panencephalitis patients in Karachi, Pakistan. Neuroepidemiology 11, 282-287.
40. Tariq WUZ, Waqar T & Ghani E (2001) Subacute sclerosing panencephalitis - a Pakistan perspective. Tropical Doctor 31, 110.
41. Vardas E, Leary PM, Yeats J, Badrodien W & Kreis S (1999) Case report and molecular analysis of subacute sclerosing panencephalitis in a South African child. Journal of Clinical Microbiology 37, 775-777.
42. Vucenovic V & Vranjesevic D (1989) SSPE - epidemiology and measles vaccination: our cases. Neurology 38, 23-31.
43. Yalaz K, Anlar B, Renda Y, Aysun S, Topcu M & Özdirim E (1988) Subacute sclerosing panencephalitis in Turkey: epidemiologic features. Journal of Tropical Pediatrics 34, 301-305.
44. Yaqub BA (1996) Subacute sclerosing panencephalitis (SSPE): early diagnosis, prognostic factors and natural history. Journal of Neurological Sciences 139, 227-234.